05/12/2023
US Patent Granted
05/12/2023
2nd (progress) discussion with FDA
05/12/2023
2nd Clinical Trial (RCT)
05/12/2023
CE Mark
05/12/2023
Japanese Patent Granted
05/12/2023
1st Clinical Trial (Pilot)
04/12/2023
NEOTEC (CDTI non dilutive funding)
08/04/2021